# To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).

> **NCT03162419** · NA · WITHDRAWN · sponsor: **Institute of Liver and Biliary Sciences, India**

## Conditions studied

- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Standard Medical Therapy
- **BIOLOGICAL:** Plasma Exchange
- **BIOLOGICAL:** GCSF

## Key facts

- **NCT ID:** NCT03162419
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-05-01
- **Primary completion:** 2019-04-25
- **Final completion:** 2019-04-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of Funds.
- **Last updated:** 2018-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162419, "To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03162419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*